FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply

1. Pfizer's pediatric COVID-19 vaccine may lose FDA authorization this fall. 2. Moderna aims to fill gaps in vaccine supply for young children. 3. Low vaccine uptake rates concern health experts amid potential supply shortages. 4. Moderna's vaccine is currently limited to specific health condition cases. 5. CDC is negotiating with Moderna to expedite vaccine supplies for children.